Decisions 4th June 2013


Recent JFG Decisions

 

At the meeting on the 4th June 2013 the following decisions / changes to the formulary were agreed

 

New Drug Requests

Approved

Insulin Degludec

  • Approved for patients who have failed on insulin glargine and are not suitable or who have failed on insulin pump therapy, TLS Red.

 

Deferred

Lixisenatide

  • Await public health appriasal of newly published trial data - to be re-discussed at the meeting 23rd July.

 

Specialised Commissioning

Aztreonam

  • Specialised Commissioning policy for the treatment of Adult and Children with Cystic Fibrosis - to be added to formulary, TLS Red.

 

Shared Care Protocols

Lithium

  • Updated SCP

 

Other Decisions

Oxybutynin

  • Clinical need in certain departments, to be added back to formulary second line TLS Blue.

 

Retigabine

  • Changed from TLS amber to TLS Red due to additional safety warnings.

 

Strontium

  • Added MHRA warning and restirctions on licensed indications

 

Last updated by: on 01-08-2013 09:47